320 related articles for article (PubMed ID: 32486909)
21. Pituitary adenylate cyclase activating polypeptide expression in sensory neurons.
Mulder H; Uddman R; Moller K; Zhang YZ; Ekblad E; Alumets J; Sundler F
Neuroscience; 1994 Nov; 63(1):307-12. PubMed ID: 7898655
[TBL] [Abstract][Full Text] [Related]
22. PACAP-38 Induces Transcriptomic Changes in Rat Trigeminal Ganglion Cells Related to Neuroinflammation and Altered Mitochondrial Function Presumably via PAC1/VPAC2 Receptor-Independent Mechanism.
Takács-Lovász K; Kun J; Aczél T; Urbán P; Gyenesei A; Bölcskei K; Szőke É; Helyes Z
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216232
[TBL] [Abstract][Full Text] [Related]
23. Pituitary adenylate cyclase-activating peptide induces neurite outgrowth in cultured monkey trigeminal ganglion cells: involvement of receptor PAC1.
Nakajima E; Walkup RD; Fujii A; Shearer TR; Azuma M
Mol Vis; 2013; 19():174-83. PubMed ID: 23378731
[TBL] [Abstract][Full Text] [Related]
24. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence.
Moller K; Zhang YZ; Håkanson R; Luts A; Sjölund B; Uddman R; Sundler F
Neuroscience; 1993 Dec; 57(3):725-32. PubMed ID: 7508577
[TBL] [Abstract][Full Text] [Related]
25. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
[TBL] [Abstract][Full Text] [Related]
26. CGRP and the Trigeminal System in Migraine.
Iyengar S; Johnson KW; Ossipov MH; Aurora SK
Headache; 2019 May; 59(5):659-681. PubMed ID: 30982963
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model.
Zhang L; Zhou Y; Wang Y; Yang L; Wang Y; Shan Z; Liang J; Xiao Z
Cephalalgia; 2023 Apr; 43(4):3331024231163131. PubMed ID: 36946245
[TBL] [Abstract][Full Text] [Related]
28. Progesterone distribution in the trigeminal system and its role to modulate sensory neurotransmission: influence of sex.
Maddahi A; Warfvinge K; Holm A; Edvinsson JCA; Reducha PV; Kazantzi S; Haanes KA; Edvinsson L
J Headache Pain; 2023 Nov; 24(1):154. PubMed ID: 37957603
[TBL] [Abstract][Full Text] [Related]
29. Capsaicin-evoked release of pituitary adenylate cyclase activating peptide (PACAP) and calcitonin gene-related peptide (CGRP) from rat spinal cord in vivo.
Zhang Y; Malmberg AB; Yaksh TL; Sjölund B; Sundler F; Håkanson R
Regul Pept; 1997 Mar; 69(2):83-7. PubMed ID: 9178350
[TBL] [Abstract][Full Text] [Related]
30. Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice.
Németh J; Reglödi D; Pozsgai G; Szabó A; Elekes K; Pintér E; Szolcsányi J; Helyes Z
Neuroscience; 2006 Nov; 143(1):223-30. PubMed ID: 16938409
[TBL] [Abstract][Full Text] [Related]
31. Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion.
Eftekhari S; Salvatore CA; Calamari A; Kane SA; Tajti J; Edvinsson L
Neuroscience; 2010 Aug; 169(2):683-96. PubMed ID: 20472035
[TBL] [Abstract][Full Text] [Related]
32. Peripheral CCL2-CCR2 signalling contributes to chronic headache-related sensitization.
Ryu S; Liu X; Guo T; Guo Z; Zhang J; Cao YQ
Brain; 2023 Oct; 146(10):4274-4291. PubMed ID: 37284790
[TBL] [Abstract][Full Text] [Related]
33. Cellular distribution of PACAP-38 and PACAP receptors in the rat brain: Relation to migraine activated regions.
Warfvinge K; Edvinsson L
Cephalalgia; 2020 May; 40(6):527-542. PubMed ID: 31810401
[TBL] [Abstract][Full Text] [Related]
34. Neurokinins and their receptors in the rat trigeminal system: Differential localization and release with implications for migraine pain.
Edvinsson JC; Reducha PV; Sheykhzade M; Warfvinge K; Haanes KA; Edvinsson L
Mol Pain; 2021; 17():17448069211059400. PubMed ID: 34898306
[TBL] [Abstract][Full Text] [Related]
35. PAC
Tasma Z; Siow A; Harris PWR; Brimble MA; O'Carroll SJ; Hay DL; Walker CS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430275
[TBL] [Abstract][Full Text] [Related]
36. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
Messlinger K; Fischer MJ; Lennerz JK
Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
[TBL] [Abstract][Full Text] [Related]
38. Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion.
Edvinsson L; Grell AS; Warfvinge K
J Mol Neurosci; 2020 Jun; 70(6):930-944. PubMed ID: 32086679
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptide FF receptor 2 inhibits capsaicin-induced CGRP Upregulation in mouse trigeminal ganglion.
Lin YT; Yu Z; Tsai SC; Hsu PH; Chen JC
J Headache Pain; 2020 Jul; 21(1):87. PubMed ID: 32640973
[TBL] [Abstract][Full Text] [Related]
40. From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment.
Tanaka M; Szabó Á; Körtési T; Szok D; Tajti J; Vécsei L
Cells; 2023 Nov; 12(22):. PubMed ID: 37998384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
